Back
Lexicon Pharmaceuticals, Inc. 10K Form
Sell
40
LXRX
Lexicon Pharmaceuticals, Inc.
Last Price:
$1.41
Seasonality Move:
20.82%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive LXRX News And Ratings
See the #1 stock for the next 7 days that we like better than LXRX
LXRX Financial Statistics
Sales & Book Value
| Annual Sales: | $31.1M |
|---|---|
| Cash Flow: | $-23.8M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.33 |
| Price / Book: | 4.23 |
Profitability
| EPS (TTM): | -0.18950 |
|---|---|
| Net Income (TTM): | $-68.6M |
| Gross Margin: | $29.9M |
| Return on Equity: | -49.19% |
| Return on Assets: | -25.42% |
Lexicon Pharmaceuticals, Inc. Earnings Forecast
Key Lexicon Pharmaceuticals, Inc. Financial Ratios
-
The Gross Profit Margin over the past 29 years for LXRX is 96.30%.
-
The Selling, General & Administrative Expenses for LXRX have been equal to 460.42% of Gross Profit Margin.
-
The Research & Development expenses have been 266.55% of Revenue.
-
The Net Earning history of LXRX is -644.78% of Total Revenues.
-
Per Share Earnings over the last 29 years have been positive in 15 years.
Lexicon Pharmaceuticals, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | LXRX |
| CUSIP: | 528872 |
| Website: | lexpharma.com |
Debt
| Debt-to-Equity Ratio: | 0.54 |
|---|---|
| Current Ratio: | 5.64 |
| Quick Ratio: | 5.45 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
LXRX Technical Analysis vs Fundamental Analysis
Sell
40
Lexicon Pharmaceuticals, Inc. (LXRX)
is a Sell
Is Lexicon Pharmaceuticals, Inc. a Buy or a Sell?
-
Lexicon Pharmaceuticals, Inc. stock is rated a SellThe current Lexicon Pharmaceuticals, Inc. [LXRX] share price is $1.40. The Score for LXRX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.